Drug intelligence / Profile preview

Hepadetox Plus

Development stage: Preclinical
Lead developer: Natural Solutions
Administration: Oral

Overview

Hepadetox Plus is a polyherbal formulation developed by Natural Solutions (India) Pvt. Ltd., currently in the preclinical stage of development. It is specifically designed to address liver health through three primary therapeutic avenues: liver detoxification, hepatoprotection, and the management of hepatic fibrosis. As a polyherbal product, it likely utilizes a synergistic blend of standardized botanical extracts known for their antioxidant and anti-inflammatory properties to protect hepatocytes from damage and inhibit the pathways leading to collagen deposition and scarring in the liver. The formulation is intended to provide a natural therapeutic option for patients at risk of or suffering from chronic liver conditions characterized by fibrotic progression.

Brand names: Hepadetox Plus

Beyond the preview

Go deeper on Hepadetox Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepadetox Plus.

Explore the full profile